TIN is focused on advancing Therapies and
Treatments to benefit those living with an
Inherited Neuropathy.

As a group, these are known as
Charcot-Marie-Tooth (CMT) disorders.

Latest News

Accelerating Answers for CMT Patients

We’re excited to announce three groundbreaking research projects focused on accelerating answers for people living with Charcot Marie Tooth disease. These innovative studies push beyond traditional approaches, targeting the biology of CMT in bold new ways — with the...

Therapies for Inherited Neuropathies Announces 2026 TIN CUP for CMT

The TIN CUP for CMT Therapies for Inherited Neuropathies (TIN) is a fully accredited 501(C)3 nonprofit whose sole focus is dedicated to identifying and advancing research and projects that bring solutions and treatments to Charcot-Marie-Tooth patients....

Topline Results from NMD’s Phase 2a Study of Ignaseclant with CMT patients!

NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2 Exploratory Phase 2a study showed consistent and clinically meaningful functional improvements across muscle strength, motor performance, and...

Therapies for Inherited Neuropathies is a registered 501(C)(3) health organization, focused on improving the lives of people with Charcot-Marie-Tooth disease

Solutions Now

Physical therapy videos and articles dedicated to expert insights on the latest treatment options, and practical therapies designed to improve mobility, reduce symptoms, and enhance daily life.

Physical Therapy Self-Help Videos

Physical Therapy Snack Videos

Keep Moving PT Articles

Lifestrength PT Connections Series

Help on the Way

TIN is dedicated to advancing research initiatives to better understand, diagnose, and treat CMT. Collaborating with researchers, clinicians, and the CMT community, we aim to accelerate innovative therapies for those living with CMT.

Research Partners Network

CMT Test in a Dish

Antibody to Stop CMT

Fingolimod to Treat CMT

Exercise Yields Benefits

1:2500

CMT affects 1 in 2500 people, meaning more than three million people world-wide are affected with Charcot Marie Tooth (CMT)

2

Current treatment options are limited to bracing, and surgery in some cases

130,000+

Those affected in the US population. CMT impacts those of all ages, sex, faith or race

Proud of the company we keep

Our Board members and Advisors have made a commitment to contribute their expert skills to a common goal: Improving the lives of members of the CMT community